CN110475784B - 用于制备立体限定硫代磷酸酯寡核苷酸的正交保护基 - Google Patents

用于制备立体限定硫代磷酸酯寡核苷酸的正交保护基 Download PDF

Info

Publication number
CN110475784B
CN110475784B CN201880022722.3A CN201880022722A CN110475784B CN 110475784 B CN110475784 B CN 110475784B CN 201880022722 A CN201880022722 A CN 201880022722A CN 110475784 B CN110475784 B CN 110475784B
Authority
CN
China
Prior art keywords
group
alkyl
aryl
amine
chiral auxiliary
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201880022722.3A
Other languages
English (en)
Chinese (zh)
Other versions
CN110475784A (zh
Inventor
K·布莱谢尔
E·D·丰德
D·J·汉森
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Roche Innovation Center Copenhagen AS
Original Assignee
Roche Innovation Center Copenhagen AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roche Innovation Center Copenhagen AS filed Critical Roche Innovation Center Copenhagen AS
Publication of CN110475784A publication Critical patent/CN110475784A/zh
Application granted granted Critical
Publication of CN110475784B publication Critical patent/CN110475784B/zh
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00Processes for the preparation of sugar derivatives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06Pyrimidine radicals
    • C07H19/10Pyrimidine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • C07H21/02Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids with ribosyl as saccharide radical
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • C07H21/04Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids with deoxyribosyl as saccharide radical
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
CN201880022722.3A 2017-03-29 2018-03-20 用于制备立体限定硫代磷酸酯寡核苷酸的正交保护基 Active CN110475784B (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP17163506.3 2017-03-29
EP17163506 2017-03-29
PCT/EP2018/057069 WO2018177825A1 (en) 2017-03-29 2018-03-20 Orthogonal protecting groups for the preparation of stereodefined phosphorothioate oligonucleotides

Publications (2)

Publication Number Publication Date
CN110475784A CN110475784A (zh) 2019-11-19
CN110475784B true CN110475784B (zh) 2024-07-16

Family

ID=61899189

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201880022722.3A Active CN110475784B (zh) 2017-03-29 2018-03-20 用于制备立体限定硫代磷酸酯寡核苷酸的正交保护基

Country Status (6)

Country Link
US (1) US11591362B2 (https=)
EP (1) EP3601309A1 (https=)
JP (1) JP7164540B2 (https=)
KR (1) KR20190135494A (https=)
CN (1) CN110475784B (https=)
WO (1) WO2018177825A1 (https=)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019002237A1 (en) 2017-06-28 2019-01-03 Roche Innovation Center Copenhagen A/S METHOD OF MULTIPLE COUPLING AND OXIDATION
KR102723989B1 (ko) 2017-12-01 2024-11-01 더 텍사스 에이 & 엠 유니버시티 시스템 엔젤만 증후군 안티센스 치료
WO2020104492A1 (en) * 2018-11-22 2020-05-28 Roche Innovation Center Copenhagen A/S Pyridinium salts as activators in the synthesis of stereodefined oligonucleotides
JP2022525541A (ja) 2019-03-20 2022-05-17 ウェイブ ライフ サイエンシズ リミテッド オリゴヌクレオチド調製に有用な技術
US12421268B2 (en) * 2019-04-16 2025-09-23 Roche Innovation Center Copenhagen A/S Process for preparing nucleotide P(V) monomers
TW202241454A (zh) * 2021-02-01 2022-11-01 日商第一三共股份有限公司 抗體-免疫賦活化劑共軛物之新穎製造方法
CN116867795A (zh) * 2021-02-01 2023-10-10 第一三共株式会社 抗体-免疫刺激剂偶联物的新型制造方法

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104661664A (zh) * 2012-07-13 2015-05-27 威尔生命科学私人有限公司 手性控制

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6465628B1 (en) 1999-02-04 2002-10-15 Isis Pharmaceuticals, Inc. Process for the synthesis of oligomeric compounds
US6492171B2 (en) 2000-05-16 2002-12-10 Isis Pharmaceuticals, Inc. Antisense modulation of TERT expression
WO2005092909A1 (ja) 2004-03-25 2005-10-06 Toudai Tlo, Ltd. 立体規則性の高いリボヌクレオチド類縁体及びデオキシリボヌクレオチド類縁体の製造法
WO2007090071A2 (en) 2006-01-27 2007-08-09 Isis Pharmaceuticals, Inc. 6-modified bicyclic nucleic acid analogs
EP2007888A2 (en) 2006-04-03 2008-12-31 Santaris Pharma A/S Pharmaceutical composition comprising anti-mirna antisense oligonucleotides
EP2623599B1 (en) 2007-10-04 2019-01-02 Roche Innovation Center Copenhagen A/S Micromirs
US9290534B2 (en) 2008-04-04 2016-03-22 Ionis Pharmaceuticals, Inc. Oligomeric compounds having at least one neutrally linked terminal bicyclic nucleoside
DK2356129T3 (da) 2008-09-24 2013-05-13 Isis Pharmaceuticals Inc Substituerede alpha-L-bicykliske nukleosider
CN102282155B (zh) 2008-12-02 2017-06-09 日本波涛生命科学公司 磷原子修饰的核酸的合成方法
RU2612521C2 (ru) * 2009-07-06 2017-03-09 Онтории, Инк. Новые пролекарства нуклеиновых кислот и способы их применения
JP5868324B2 (ja) 2010-09-24 2016-02-24 株式会社Wave Life Sciences Japan 不斉補助基
WO2017157672A1 (en) 2016-03-18 2017-09-21 Roche Innovation Center Copenhagen A/S Acyl-protected l-lna-guanosine monomers
EP3455232B1 (en) * 2016-05-12 2020-05-06 Roche Innovation Center Copenhagen A/S Enhanced coupling of stereodefined oxazaphospholidine phosphoramidite monomers to nucleoside or oligonucleotide
EP3458464B1 (en) * 2016-05-18 2026-04-15 ETH Zurich Stereoselective synthesis of phosphorothioate oligoribonucleotides

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104661664A (zh) * 2012-07-13 2015-05-27 威尔生命科学私人有限公司 手性控制

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Solid-Phase Synthesis of Stereoregular Oligodeoxyribonucleoside Phosphorothioates Using Bicyclic Oxazaphospholidine Derivatives as Monomer Units;Natsuhisa Oka, et al.;《Journal of the American Chemical Society》;20081231;第130卷(第47期);第16031-16037 *

Also Published As

Publication number Publication date
WO2018177825A1 (en) 2018-10-04
US11591362B2 (en) 2023-02-28
JP2020512360A (ja) 2020-04-23
CN110475784A (zh) 2019-11-19
JP7164540B2 (ja) 2022-11-01
US20210179658A1 (en) 2021-06-17
EP3601309A1 (en) 2020-02-05
KR20190135494A (ko) 2019-12-06

Similar Documents

Publication Publication Date Title
CN110475784B (zh) 用于制备立体限定硫代磷酸酯寡核苷酸的正交保护基
JP7492829B2 (ja) 多重カップリングおよび酸化の方法
JP7097820B2 (ja) ヌクレオシドまたはオリゴヌクレオチドへの、立体的に規定されたオキサザホスホリジンホスホルアミダイト単量体のカップリングの増大法
JP7017517B2 (ja) アシル保護l-lna-グアノシンモノマー
WO2000020431A1 (en) Improved process for oligonucleotide synthesis
JP7198768B2 (ja) UnyLinker迅速切断方法
JP7759323B2 (ja) 核酸オリゴマーの製造方法
JP7698631B2 (ja) 核酸オリゴマーの製造方法
KR20250042734A (ko) 올리고뉴클레오티드의 제조 방법
HK40017810A (en) Orthogonal protecting groups for the preparation of stereodefined phosphorothioate oligonucleotides
HK40017810B (zh) 用於制备立体限定硫代磷酸酯寡核苷酸的正交保护基
HK40016121A (en) Unylinker rapid cleavage
HK40022416A (en) Multiple coupling & oxidation method
HK40022416B (zh) 多重偶联和氧化方法
HK40003927A (en) Enhanced coupling of stereodefined oxazaphospholidine phosphoramidite monomers to nucleoside or oligonucleotide
HK40003927B (en) Enhanced coupling of stereodefined oxazaphospholidine phosphoramidite monomers to nucleoside or oligonucleotide

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 40017810

Country of ref document: HK

GR01 Patent grant
GR01 Patent grant
TG01 Patent term adjustment
TG01 Patent term adjustment

Free format text: NEW EXPIRY DATE: 20380708